On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
60° Feels Like: 60°
Wind: NNW 15 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 65°

Tonight

Scattered Thunderstorms 49°

Tomorrow

AM Clouds/PM Sun 62°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Gilead says on track with hepatitis C treatments

(Reuters) - Gilead Sciences Inc is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus (HCV) infection, starting in mid-2013, the biotech company said on Monday.

Gilead is scheduled to give investors an update on its candidates for HCV treatment at a JPMorgan healthcare conference this week in San Francisco.

The company will discuss new results from an arm of a continuing Phase 2 trial and provide a progress report on a range of Phase 2 and 3 trials evaluating a once-daily fixed-dose combination tablet of the medicines.

(Reporting by Debra Sherman; editing by John Wallace)

Comments